Assessment of neuroprotection in the retina with DARC

[1]  S. Wolf,et al.  Distribution of amyloid precursor protein and amyloid-beta immunoreactivity in DBA/2J glaucomatous mouse retinas. , 2007, Investigative ophthalmology & visual science.

[2]  A. Sillito,et al.  Targeting amyloid-β in glaucoma treatment , 2007, Proceedings of the National Academy of Sciences.

[3]  T. Salt,et al.  Topical CoQ10 Is Neuroprotective in Experimental Glaucoma , 2007 .

[4]  Fatmire Berisha,et al.  Retinal abnormalities in early Alzheimer's disease. , 2007, Investigative ophthalmology & visual science.

[5]  T. Salt,et al.  Assessment of Rat and Mouse RGC Apoptosis Imaging in Vivo with Different Scanning Laser Ophthalmoscopes , 2007, Current eye research.

[6]  C. Nucci,et al.  Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat. , 2007, International review of neurobiology.

[7]  Jiankang Liu.  The Effects and Mechanisms of Mitochondrial Nutrient α-Lipoic Acid on Improving Age-Associated Mitochondrial and Cognitive Dysfunction: An Overview , 2007, Neurochemical Research.

[8]  J. Y. Ku,et al.  Correlation of retinal nerve fiber layer measured by scanning laser polarimeter to visual field in ischemic optic neuropathy. , 2006, Archives of ophthalmology.

[9]  K. Lu,et al.  Pathogenic mechanisms in Alzheimer's disease. , 2006, European journal of pharmacology.

[10]  R. Sullivan,et al.  Evoked expression of the glutamate transporter GLT-1c in retinal ganglion cells in human glaucoma and in a rat model. , 2006, Investigative ophthalmology & visual science.

[11]  T. Kanamoto,et al.  High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease , 2006, Journal of the Neurological Sciences.

[12]  David H. Cribbs,et al.  Novel approaches for immunotherapeutic intervention in Alzheimer's disease , 2006, Neurochemistry International.

[13]  T. Salt,et al.  Glutamate excitotoxicity in glaucoma: throwing the baby out with the bathwater? , 2006, Eye.

[14]  G. Levy,et al.  A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS , 2006, Neurology.

[15]  N. Yüksel,et al.  Relationship between Cognitive Impairment and Retinal Morphological and Visual Functional Abnormalities in Alzheimer Disease , 2006, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[16]  Robert N Weinreb,et al.  Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. , 2006, Archives of ophthalmology.

[17]  T. Salt,et al.  Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo. , 2006, Investigative ophthalmology & visual science.

[18]  J. Growdon,et al.  Current pharmacotherapy for Alzheimer's disease. , 2006, Annual review of medicine.

[19]  Philip P. Chen,et al.  A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. , 2006, Archives of ophthalmology.

[20]  D. Jackson,et al.  En face optical coherence tomography: a new method to analyse structural changes of the optic nerve head in rat glaucoma , 2005, British Journal of Ophthalmology.

[21]  B. Chauhan,et al.  Functional assessment of glutamate clearance mechanisms in a chronic rat glaucoma model using retinal ganglion cell calcium imaging , 2005, Journal of neurochemistry.

[22]  M. Sikorska,et al.  Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10 , 2005, Neurobiology of Disease.

[23]  Young H. Kwon,et al.  Memantine and progressive glaucoma. , 2005, Journal of glaucoma.

[24]  P. Kaufman,et al.  Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma. , 2005, Archives of ophthalmology.

[25]  F. Fitzke,et al.  Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. , 2005, Investigative ophthalmology & visual science.

[26]  H. Hara,et al.  Vitreous fluid levels of β-amyloid(1–42) and tau in patients with retinal diseases , 2005, Japanese Journal of Ophthalmology.

[27]  S. Lipton.  Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. , 2005, Journal of Alzheimer's disease : JAD.

[28]  C. Reutelingsperger,et al.  Cell Surface-expressed Phosphatidylserine and Annexin A5 Open a Novel Portal of Cell Entry* , 2004, Journal of Biological Chemistry.

[29]  S McCarthy,et al.  Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10. , 2004, Toxicology and applied pharmacology.

[30]  H. Hara,et al.  Neuroprotective effects of β-secretase inhibitors against rat retinal ganglion cell death , 2004, Neuroscience Letters.

[31]  Li Guo,et al.  Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Woldemussie,et al.  Müller cell response to laser‐induced increase in intraocular pressure in rats , 2004, Glia.

[33]  L. Zangwill,et al.  Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures. , 2004, Investigative ophthalmology & visual science.

[34]  R. Stout,et al.  Laser Doppler Flowmetry Study of Systemic Vasoconstriction after Topical 2.5% Phenylephrine Eye Drops , 2004 .

[35]  M. Daemen,et al.  Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. , 2004, The New England journal of medicine.

[36]  Akihiro Noda,et al.  18F-labelled annexin V: a PET tracer for apoptosis imaging , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[37]  G. Slegers,et al.  Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  P. Thimister,et al.  Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-annexin A5. , 2003, The British journal of radiology.

[39]  Donald J Zack,et al.  A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. , 2003, Investigative ophthalmology & visual science.

[40]  Ewa Witort,et al.  Coenzyme Q10 Prevents Apoptosis by Inhibiting Mitochondrial Depolarization Independently of Its Free Radical Scavenging Property* , 2003, Journal of Biological Chemistry.

[41]  J. Robbins,et al.  Enhancement of low-voltage-activated calcium currents by group II metabotropic glutamate receptors in rat retinal ganglion cells , 2003, Molecular and Cellular Neuroscience.

[42]  P. Gain,et al.  Mechanisms of staurosporine induced apoptosis in a human corneal endothelial cell line , 2003, The British journal of ophthalmology.

[43]  Young H. Kwon,et al.  Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. , 2003, Archives of ophthalmology.

[44]  J. Ram,et al.  Neuroprotection in glaucoma. , 2003, Journal of postgraduate medicine.

[45]  M. Schwartz,et al.  Neuroprotective Effect of Memantine in Different Retinal Injury Models in Rats , 2002, Journal of glaucoma.

[46]  M. Citron.  β‐secretase as a target for the treatment of Alzheimer's disease , 2002 .

[47]  R. Quirion,et al.  Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies , 2002, Progress in Neurobiology.

[48]  F. Blankenberg,et al.  Imaging cell death with radiolabeled annexin V in an experimental model of rheumatoid arthritis. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[49]  H. Quigley,et al.  Measurement of amino acid levels in the vitreous humor of rats after chronic intraocular pressure elevation or optic nerve transection. , 2002, Journal of glaucoma.

[50]  F. Tortella,et al.  Selective NR2B NMDA receptor antagonists are protective against staurosporine-induced apoptosis. , 2002, European journal of pharmacology.

[51]  David Zurakowski,et al.  Effects of anti-glaucoma medications on gangion cell survival: the DBA/2J mouse model , 2002, Vision Research.

[52]  Alexander J. Rivest,et al.  The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Earl L. Smith,et al.  Vitreal glutamate concentration in monkeys with experimental glaucoma. , 2002, Investigative ophthalmology & visual science.

[54]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[55]  H. Quigley,et al.  Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat. , 2002, Investigative ophthalmology & visual science.

[56]  D. Hodge,et al.  Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. , 2002, American journal of ophthalmology.

[57]  K. Park,et al.  Neuroprotective effect of memantine in a rabbit model of optic nerve ischemia. , 2002, Korean journal of ophthalmology : KJO.

[58]  D. Zack,et al.  Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. , 2002, Investigative ophthalmology & visual science.

[59]  Andreas U Bayer,et al.  Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. , 2002, American journal of ophthalmology.

[60]  P. Doevendans,et al.  Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart , 2001, Nature Medicine.

[61]  F. Blankenberg,et al.  Annexin-V imaging for noninvasive detection of cardiac allograft rejection , 2001, Nature Medicine.

[62]  F. Pierelli,et al.  Morphological and functional retinal impairment in Alzheimer's disease patients , 2001, Clinical Neurophysiology.

[63]  E. Ségal-Bendirdjian,et al.  Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms , 2001, Oncogene.

[64]  P. Thimister,et al.  In vivo detection of apoptosis in an intracardiac tumor. , 2001, JAMA.

[65]  S. D'Anna,et al.  Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. , 2001, Investigative ophthalmology & visual science.

[66]  S. Lipton.  Retinal ganglion cells, glaucoma and neuroprotection. , 2001, Progress in brain research.

[67]  H. Wellens,et al.  Cardiomyocyte Death Induced by Myocardial Ischemia and Reperfusion: Measurement With Recombinant Human Annexin-V in a Mouse Model , 2000, Circulation.

[68]  R. Motter,et al.  Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease , 2000, Nature Medicine.

[69]  F W Fitzke,et al.  Imaging the optic nerve and ganglion cell layer , 2000, Eye.

[70]  H. Wässle,et al.  Synaptic localization of NMDA receptor subunits in the rat retina , 2000, The Journal of comparative neurology.

[71]  H. Quigley,et al.  Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. , 2000, Investigative ophthalmology & visual science.

[72]  E. Guenther,et al.  Coexpression patterns of mGLuR mRNAs in rat retinal ganglion cells: a single-cell RT-PCR study. , 2000, Investigative ophthalmology & visual science.

[73]  B. Kagan,et al.  Alzheimer amyloid aβ1–42 channels: Effects of solvent, pH, and congo red , 1999, Journal of neuroscience research.

[74]  K. Bales,et al.  Neuroprotection by metabotropic glutamate receptor agonists: LY354740, LY379268 and LY389795 , 1999 .

[75]  F. Minvielle,et al.  Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder. , 1999, Investigative ophthalmology & visual science.

[76]  N. Osborne.  Memantine reduces alterations to the mammalian retina, in situ, induced by ischemia , 1999, Visual Neuroscience.

[77]  G. Berry,et al.  The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. , 1998, The Journal of thoracic and cardiovascular surgery.

[78]  Douglas R. Anderson,et al.  Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. , 1998, American journal of ophthalmology.

[79]  Alex R. Wade,et al.  A fast, robust pattern recognition asystem for low light level image registration and its application to retinal imaging. , 1998, Optics express.

[80]  M. Slaughter,et al.  Metabotropic and ionotropic glutamate receptors regulate calcium channel currents in salamander retinal ganglion cells , 1998, The Journal of physiology.

[81]  S. Archer,et al.  Expression and localization in the fish retina of a homologue of the Alzheimer's related PS1 gene , 1998, Neuroreport.

[82]  R. Davis,et al.  In vivo detection and imaging of phosphatidylserine expression during programmed cell death. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[83]  S. Sharma,et al.  MK801—a neuroprotectant in rat hypertensive eyes , 1998, Brain Research.

[84]  M. Bach,et al.  Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. , 1998, Investigative ophthalmology & visual science.

[85]  M. O'Neill,et al.  Neuroprotective effects of a systemically active Group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia , 1998, Neuroreport.

[86]  D. Zack,et al.  TUNEL-positive ganglion cells in human primary open-angle glaucoma. , 1997, Archives of ophthalmology.

[87]  D. Zurakowski,et al.  Vitreous body glutamate concentration in dogs with glaucoma. , 1997, American journal of veterinary research.

[88]  Ronald G. Thomas,et al.  Defective neurite extension is caused by a mutation in amyloid β/A4 (Aβ) protein precursor found in Familial Alzheimer's Disease , 1997 .

[89]  D. Schoepp,et al.  Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. , 1997, Journal of medicinal chemistry.

[90]  F. Nicoletti,et al.  Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? , 1996, Trends in Neurosciences.

[91]  R. Blanks,et al.  Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL , 1996, Neurobiology of Aging.

[92]  R. Blanks,et al.  Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina , 1996, Neurobiology of Aging.

[93]  S M Podos,et al.  Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. , 1996, Archives of ophthalmology.

[94]  J. Morrison,et al.  Intraperikaryal Neurofilamentous Accumulations in a Subset of Retinal Ganglion Cells in Aged Mice That Express a Human Neurofilament Gene , 1995, Experimental Neurology.

[95]  D. Choi,et al.  Staurosporine-Induced Neuronal Apoptosis , 1995, Experimental Neurology.

[96]  H. Wässle,et al.  Expression of the mRNA of Seven Metabotropic Glutamate Receptors (mGluR1 to 7) in the Rat Retina. An In Situ Hybridization Study on Tissue Sections and Isolated Cells , 1995, The European journal of neuroscience.

[97]  F W Fitzke,et al.  Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. , 1995, The British journal of ophthalmology.

[98]  D. Zack,et al.  Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. , 1995, Investigative ophthalmology & visual science.

[99]  M. Tso,et al.  Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina. , 1995, Investigative ophthalmology & visual science.

[100]  B. Yankner,et al.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[101]  C. Reutelingsperger,et al.  Expression on B Cells Undergoing Apoptosis Annexin V for Flow Cytometric Detection of Phosphatidylserine , 2022 .

[102]  H. Wässle,et al.  Expression of NMDA and High‐affinity Kainate Receptor Subunit mRNAs in the Adult Rat Retina , 1994, The European journal of neuroscience.

[103]  S. Lipton.  Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide , 1993, Trends in Neurosciences.

[104]  S. Heinemann,et al.  Expression of glutamate receptor genes in the mammalian retina: the localization of GluR1 through GluR7 mRNAs , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[105]  A. Reder,et al.  MK-801 protects retinal neurons from hypoxia and the toxicity of glutamate and aspartate. , 1992, Investigative ophthalmology & visual science.

[106]  V. Fadok,et al.  Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. , 1992, Journal of immunology.

[107]  D. Lucas,et al.  The toxic effect of sodium L-glutamate on the inner layers of the retina. , 1957, A.M.A. archives of ophthalmology.